In what situation, if any, would you combine immunotherapy concurrently with radiation for patients with head and neck cancer?

In the definitive setting I would only use this combination in the setting of a clinical trial. In the recurrent/metastatic setting would consider for patients in need of palliation or with progression in a limited number of sites (with good responses elsewhere). I would prefer this be done on proto...